KCAS Bio will participate in AAPS 2025 PharmSci 360, taking place November 9-12 in San Antonio, TX.
AAPS 2025 PharmSci 360 gathers industry professionals for a conference that covers the full spectrum of drug development. Topics will cover preclinical research, bioanalytics, clinical pharmacology, formulation, manufacturing, and regulatory science. These topics converge innovation, policy, and professional development, providing a 360-degree view of the pharmaceutical sciences. The comprehensive program will feature presentations, interactive exhibits, and networking- all designed to spark collaboration and advance innovation across the pharmaceutical industry.
Pharmaceutical Sciences at KCAS Bio
KCAS Bio provides advanced bioanalytical and biomarker development services that align closely with the scope of AAPS PharmSci 360. Our expertise spans regulated and non-regulated assay development to support pharmacokinetic, pharmacodynamic, and immunogenicity assessments across a broad range of therapeutic platforms. We leverage advanced technologies to generate decision-enabling data that accelerate the stages of drug development. Our scientific teams work collaboratively with sponsors to design fit-for-purpose assays that meet evolving regulatory expectations and complex study requirements.
Commitment to Innovation
The KCAS Bio teams collaborate with industry and academic leaders to refine assay strategies, validate novel platforms, and improve data interpretation across therapeutic areas. Through scientific exchange and technical innovation, we drive more informed, efficient, and scalable approaches to drug development. KCAS Bio strives to help shape the future of science- making our attendance at AAPS 2025 PharmSci 360 valuable to our mission.
Connect With Us at AAPS 2025 PharmSci 360
Connect with us throughout AAPS 2025 PharmSci 360 to discuss drug development across every stage. Our team will be exhibiting to share our expertise at KCAS Bio and ignite collaboration that advances your bioanalytical projects. Explore how KCAS Bio can accelerate any stage of your program, from early preclinical development to formulation and analytical characterization.